Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome.

< BACK TO ARCHIVE


Papers: 14 Nov 2020 - 20 Nov 2020


Human Studies


2020 Nov 16


Clin Exp Rheumatol


http://www.ncbi.nlm.nih.gov/pubmed/33200740?dopt=Abstract

The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome.

Authors

The effect of novel coronavirus disease-2019 (COVID-19) on fibromyalgia syndrome.
Salaffi F, Giorgi V, Sirotti S, Bongiovanni S, Farah S, Bazzichi L, Marotto D, Atzeni F, Rizzi M, Batticciotto A, Lombardi G, Galli M, Sarzi-Puttini P
Clin Exp Rheumatol. 2020 Nov 16.
PMID: 33200740.

Abstract

Fibromyalgia syndrome (FM) is a complex disease that is mainly characterised by chronic widespread pain, fatigue and sleep disturbances and may be precipitated or worsened by many stressors. The aim of this study was to observe the behaviour of FM symptoms during the course of coronavirus disease 2019 (COVID-19).